Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2019 | 12-2018 | 12-2017 | |
| Operating Expenses | 14,128 | 7,494 | 1,595 |
| Operating Income | -14,128 | -7,494 | -1,595 |
| Interest Expense | 1 | 663 | 61 |
| Other Income | 444 | -7,737 | -5 |
| Pre-tax Income | -13,684 | -15,894 | -1,661 |
| Net Income Continuous | -13,684 | -15,894 | -1,661 |
| Net Income | $-13,684 | $-15,894 | $-1,661 |
| EPS Basic Total Ops | -0.53 | -1.03 | -0.07 |
| EPS Basic Continuous Ops | -0.53 | -1.03 | N/A |
| EPS Diluted Total Ops | -0.53 | -1.03 | -0.07 |
| EPS Diluted Continuous Ops | -0.53 | -1.03 | N/A |
| EBITDA(a) | $-13,533 | $-15,139 | $-1,547 |